NYSE - Nasdaq Real Time Price USD

Inspire Medical Systems, Inc. (INSP)

Compare
184.04 +7.99 (+4.54%)
As of 9:39 AM EST. Market Open.
Loading Chart for INSP
DELL
  • Previous Close 176.05
  • Open 173.53
  • Bid 182.00 x 900
  • Ask 181.45 x 800
  • Day's Range 184.04 - 188.65
  • 52 Week Range 123.00 - 257.40
  • Volume 31,959
  • Avg. Volume 595,585
  • Market Cap (intraday) 5.515B
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) 165.81
  • EPS (TTM) 1.11
  • Earnings Date Feb 4, 2025 - Feb 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 239.87

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

www.inspiresleep.com

1,011

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INSP

View More

Performance Overview: INSP

Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INSP
9.53%
S&P 500
23.58%

1-Year Return

INSP
31.23%
S&P 500
30.59%

3-Year Return

INSP
30.10%
S&P 500
25.47%

5-Year Return

INSP
187.35%
S&P 500
88.92%

Compare To: INSP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INSP

View More

Valuation Measures

Annual
As of 11/19/2024
  • Market Cap

    5.28B

  • Enterprise Value

    4.89B

  • Trailing P/E

    158.60

  • Forward P/E

    95.24

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.06

  • Price/Book (mrq)

    7.57

  • Enterprise Value/Revenue

    6.47

  • Enterprise Value/EBITDA

    126.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.37%

  • Return on Assets (ttm)

    1.17%

  • Return on Equity (ttm)

    5.33%

  • Revenue (ttm)

    755.59M

  • Net Income Avi to Common (ttm)

    33.05M

  • Diluted EPS (ttm)

    1.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    410.99M

  • Total Debt/Equity (mrq)

    3.64%

  • Levered Free Cash Flow (ttm)

    21.27M

Research Analysis: INSP

View More

Company Insights: INSP

Research Reports: INSP

View More

People Also Watch